World's Best Scientists 2026 revealed!
International Clinical Psychopharmacology
H-index 16

International Clinical Psychopharmacology

0268-1315

Published by: Wolters Kluwer Health, Inc.

https://journals.lww.com/intclinpsychopharm/pages/default.aspx

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Psychology 501 47 90 14
Medicine 1586 48 104 16

Additional Metrics

Number of Best Scientists*: 108
Documents by Best Scientists*: 142
Top 100 Ranked Scientists*: 4
SCIMAGO H-index: 100
SCIMAGO SJR: 0.642
Impact Factor: 2.5

Overview

Top Research Topics at International Clinical Psychopharmacology?

The discussions in International Clinical Psychopharmacology mainly cover the fields of Psychiatry, Internal medicine, Anesthesia, Schizophrenia and Depression (differential diagnoses). Studies on Psychiatry discussed in it link to the field of Clinical psychology. It facilitates discussions on Internal medicine that incorporate concepts from other fields like Major depressive disorder, Placebo and Endocrinology.

The main emphasis of the journal is the subject of Placebo, focusing on Placebo-controlled study. Adverse effect and Reuptake inhibitor are some topics wherein Anesthesia research discussed in International Clinical Psychopharmacology have an impact. While the journal focused on Reuptake inhibitor, it was also able to explore topics like Fluoxetine and Fluvoxamine.

The in-depth study on Schizophrenia also explores topics in the intersecting field of Psychosis. Most of the Randomized controlled trial studies addressed also intersect with Clinical trial. Discussions in International Clinical Psychopharmacology are anchored in the subject of Antidepressant and the similar topic of Pharmacology.

  • Psychiatry (38.57%)
  • Internal medicine (31.45%)
  • Anesthesia (14.42%)

What are the most cited papers published in the journal?

  • The measurement of disability. (1021 citations)
  • The Oxford companion to the mind (548 citations)
  • Depression in the community: the first pan-European study DEPRES (Depression Research in European Society) (458 citations)

Research areas of the most cited articles at International Clinical Psychopharmacology:

Psychiatry, Internal medicine, Placebo, Anesthesia and Randomized controlled trial are the main subjects of interest in the most cited papers. Many of the studies tackled in the most cited papers connect Psychiatry with a similar field of study like Clinical psychology. The published papers explore research in Major depressive disorder and overlapping concepts in Escitalopram to expand the discourse in Internal medicine.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Schizophrenia

The previous edition focused in particular on these issues:

The aim of the journal is to expand the discussion of research in Internal medicine, Antipsychotic, Pediatrics, Schizophrenia and Depression (differential diagnoses). The work on Internal medicine tackled in the journal brings together disciplines like Bipolar disorder, Placebo and Gastroenterology. While work presented in it provided substantial information on Placebo, it also covered topics in Major depressive disorder, Sertraline and Rating scale.

In addition to Schizophrenia research, it aims to explore topics under Long acting, Observational study, Psychosis and Disease. International Clinical Psychopharmacology deals with Depression (differential diagnoses) in conjunction with Dissociative and similar fields in Esketamine. The presented Huntington's disease research focuses mostly on Psychiatry and, on occasion, topics in Odds ratio.

The most cited articles from the last journal are:

  • The effects of adding long-acting injectable antipsychotic drugs to clozapine on relapse and hospitalization in patients with treatment-resistant schizophrenia: a mirror-image retrospective study. (4 citations)
  • Managing dissociative symptoms following the use of esketamine nasal spray: a case report (4 citations)
  • Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in International Clinical Psychopharmacology (based on the number of publications) are:

  • Stuart Montgomery (74 papers) absent at the last edition,
  • Abraham Weizman (56 papers) published 2 papers at the last edition, 2 less than at the previous edition,
  • Siegfried Kasper (55 papers) absent at the last edition,
  • Jun Nakamura (40 papers) absent at the last edition,
  • Y. Morokawa (38 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in International Clinical Psychopharmacology (based on the number of publications) are:

  • Imperial College London (46 papers) absent at the last edition,
  • Harvard University (35 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Tel Aviv University (34 papers) published 2 papers at the last edition, 3 less than at the previous edition,
  • Duke University (28 papers) absent at the last edition,
  • Eli Lilly and Company (28 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 15.69% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 13.95% were posted by at least one author from the top 10 institutions publishing in the journal. Another 2.33% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 9.30% of all publications and 74.42% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Further Studies in Clinical Psychopharmacology

Upon completion of studies in Clinical Psychopharmacology, graduates are often interested in the career prospects that await them in the vast medical field. The specialization offers opportunities in various capacities such as clinical pharmacologists, medical scientists, health counselors, psychiatric technicians, and psychiatric aides. These professionals work directly with patients, counsel them on their medication regimens, conduct research on new drugs, and work in coordination with other healthcare providers to manage patient care.

The career is not only rewarding from a financial perspective but also fulfilling as it involves helping individuals improve their quality of life. Furthermore, graduates who want to continue their academic journey can consider pursuing higher studies or research work.

Several prestigious institutions offer unique programs focused on psycho-pharmacological research and its clinical applications. For example, students seeking to continue their education in psychology might consider universities in Florida, known for their quality programs and research focus. You can find a detailed list of good colleges for psychology in Florida on Research.com.

Ultimately, the study and practice of Clinical Psychopharmacology offers a diverse range of career paths and academic opportunities. The satisfaction of contributing to the betterment of patients' mental health makes the journey worthwhile.

Top Publications

  • Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders

    Naomi A. Fineberg;Naomi A. Fineberg;Naomi A. Fineberg;Eric Hollander;Stefano Pallanti;Stefano Pallanti;Susanne Walitza

    (2020)
    142 Citations
  • Antidepressant psychopharmacology: is inflammation a future target?

    (2022)
    51 Citations
  • Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology.

    David Castle;Francesca Beilharz;Katharine A Phillips;Vlasios Brakoulias

    (2021)
    49 Citations
  • OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females.

    Mitchell F. Brin;Suresh Durgam;Arlene Lum;Lynn James

    (2020)
    43 Citations
  • Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology.

    Bryant Lim;Beth A Sproule;Beth A Sproule;Zarin Zahra;Nadiya Sunderji

    (2020)
    33 Citations
  • A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder

    Andrea Fagiolini;Umberto Albert;Laura Ferrando;Erik Herman

    (2020)
    31 Citations
  • Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment.

    Chiara Fabbri;Stuart Montgomery;Cathryn M. Lewis;Alessandro Serretti

    (2020)
    30 Citations

Related Online Degrees & Career Pathways

Exploring online degrees related to Medicine in the USA can open doors to diverse and rewarding career paths. For those interested in advancing clinical expertise, one option is to pursue one of the cheapest online DNP programs. These programs offer affordable routes to high-level nursing practice and leadership roles, combining flexibility with quality education.

Alternatively, careers in healthcare administration and support roles are in strong demand. Programs like medical billing and coding online schools that accept financial aid provide students with crucial skills to manage medical records and billing efficiently, often with financial assistance available to reduce costs.

Graduates with a biology degree also have lucrative career options beyond traditional roles. Many high paying jobs with a biology degree exist in fields such as biotechnology, pharmaceuticals, and research, offering strong income potential and diverse work environments.

For professionals considering certification, understanding the differences in qualifications is essential. The comparison between CCS vs CPC salary highlights how different certifications can impact earnings and job prospects in medical coding, helping candidates choose the right path for advancing their careers.

Best Scientists Contributing to This Journal